摘要 |
The present invention discloses a new polypeptide - human ATP - dependent serine protease 11.4, the polynucleotide encoding it and a method producing the polypeptide by DNA recombinant technology. The present invention further discloses a method treating various disorders, e.g., mitochondrial disease, energy and substance metabolism-related metabolic disturbance disorder, growth disturbance disorder, congenital abnormality, some tumour, genetic disease, hematopathy, and immunological disease etc. The present invention also discloses an antagonist of the polypeptide and its therapeutic action. The present invention further discloses the use of the polynucleotide encoding the new human ATP-dependent serine protease 11.4. |